1
SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Condition(s):OtotoxicityLast Updated:December 9, 2022Enrolling by invitation
Ototoxicity: 48 Clinical Trials, Page 1 of 5
Hide Studies Not Open or Pending
2
Prevention of Drug Induced Ototoxicity in Peritoneal Dialysis Patients by N-Acetylcysteine
Condition(s):Drug-induced Ototoxicity in Peritoneal Dialysis PatientsLast Updated:May 27, 2010Completed
3
Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin
Condition(s):Ototoxicity, Drug-InducedLast Updated:February 15, 2023Not yet recruiting
4
Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
Condition(s):Vestibular Schwannoma; OtotoxicityLast Updated:December 7, 2022Recruiting
5
Randomized Trial Comparison of Ototoxicity Monitoring Programs
Condition(s):Cisplatin Ototoxicity; Hearing LossLast Updated:October 9, 2019Completed
6
The Protective Effect of Ginkgo Biloba Extract on Cisplatin-induced Ototoxicity in Humans
Condition(s):Ototoxicity; Hearing LossLast Updated:June 8, 2010Completed
7
Does Aspirin Have a Protective Role Against Chemotherapeutically Induced Ototoxicity?
Condition(s):Hearing Loss; OtotoxicityLast Updated:December 21, 2007Unknown status
8
Study to Evaluate Safety and Efficacy of DB-020 to Protect Hearing in Patients Receiving Cisplatin for Cancer Treatment
Condition(s):OtotoxicityLast Updated:January 9, 2023Active, not recruiting
9
Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin
Condition(s):Ototoxicity; Unspecified Childhood Solid Tumor, Protocol SpecificLast Updated:March 13, 2017Completed
10
Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Condition(s):Osteosarcoma; Nephrotoxicity; OtotoxicityLast Updated:March 16, 2020Completed